New European Yaz Study Confirms Health Risks

The European Medicines Agency (EMA) has issued its monthly report which includes a section highlighting the risks of venous thromboembolism (VTE) for women who take Yaz and any other oral contraceptive that contains drospirenone. The EMA Pharmacovigilance Working Party (PhVWP) reviewed all available data including recent publications and information regarding the risks of VTEs associated [...]